Shifting HealthTech Investment Strategies: From Growth to Value and Quality
During the COVID-19 pandemic, health technology (healthtech) investments surged as market activity skyrocketed. However, over the past 18 months, investment volumes have trended downward due to inflation, high interest rates, and growing market uncertainty. Investors are now rethinking their strategies, moving from a focus on high-growth startups to prioritizing more established companies with proven revenue…